Cholinergic activation regulates cognitive function, particularly long-term memory consolidation. This Review presents an overview of the anatomical, neurochemical, and pharmacological evidence supporting the cholinergic regulation of Pavlovian contextual and cue-conditioned fear learning and extinction. Basal forebrain cholinergic neurons provide inputs to neocortical regions and subcortical limbic structures such as the hippocampus and amygdala. Pharmacological manipulations of muscarinic and nicotinic receptors support the role of cholinergic processes in the amygdala, hippocampus, and prefrontal cortex in modulating the learning and extinction of contexts or cues associated with threat. Additional evidence from lesion studies and analysis of in vivo acetylcholine release with microdialysis similarly support a critical role of cholinergic neurotransmission in corticoamygdalar or corticohippocampal circuits during acquisition of fear extinction. Although a few studies have suggested a complex role of cholinergic neurotransmission in the cellular plasticity essential for extinction learning, more work is required to elucidate the exact cholinergic mechanisms and physiological role of muscarinic and nicotinic receptors in these fear circuits. Such studies are important for elucidating the role of cholinergic neurotransmission in disorders such as posttraumatic stress disorder that involve deficits in extinction learning as well as for developing novel therapeutic approaches for such disorders. V C 2016 Wiley Periodicals, Inc.
Various different types of evidence implicate cholinergic signaling, particularly via activation of muscarinic cholinergic receptors (mAChR), in cognitive function and, more specifically, long-term memory consolidation (see Gold, 2003; Power et al., 2003b; Tinsley, 2004; Robinson et al., 2011) . In addition, it appears that acetylcholine (ACh) may interact with other modulators, including the noradrenergic, glucocorticoid, and histaminergic systems, to facilitate aversive learning in tasks dependent on regions such as the basolateral amygdala (BLA; Power et al., 2003b) . This cholinergic regulation is seen with both systemic and region-specific pharmacological manipulations in various learning tasks, including Pavlovian fear learning and extinction paradigms. Although other conditioned tasks are also affected by these pharmacological manipulations, this Review focuses specifically on Pavlovian contextual and cueconditioned fear responses and extinction. Other reviews have more completely covered cholinergic modulation of additional conditioned learning responses, such as inhibitory avoidance (Gold, 2003; Power et al., 2003b; Tinsley, 2004; Robinson et al., 2011; Gould and Leach, 2014) . In fear conditioning procedures, animals are conditioned by pairing a neutral stimulus, such as a tone (the conditioned stimulus [CS]), with an aversive stimulus, such as a foot shock (the unconditioned stimulus [US] ). The pairing of the CS and the US allows both the context and the CS (the tone), even when the CS is presented in a novel context, to elicit a defensive response, such as freezing (Fendt and Fanselow, 1999) . Repeated re-exposure to the context or the CS in the absence of the US results in the extinction of the response (Baldi and Bucherelli, 2015) . Various studies have demonstrated key roles for plasticity in the amygdala, hippocampus, and prefrontal cortex (PFC) in driving these conditioned fear and extinction responses (Fendt and Fanselow, 1999; Milad and Quirk, 2012; Baldi and Bucherelli, 2015) . Moreover, studies have suggested that extinction learning involves distinct neuronal populations and signaling processes from the original learning of the contextual or cue-conditioned responses (Herry et al., 2008; Tronson et al., 2009 ) and that extinction of contextual or cued fear responses appears to involve prefrontal-amygdalar and prefrontalhippocampal circuits (see Orsini and Maren, 2012; Baldi and Bucherelli, 2015; Rozeske et al., 2015) .
ANATOMY OF CHOLINERGIC REGULATION OF AMYGDALA, HIPPOCAMPUS, AND PFC
Mammalian forebrain cholinergic neurons have been broadly grouped into four clusters with the nomenclature of Mesulam and colleagues (1983b) . The first three subgroups (Ch1-3) consist of neurons in the medial septum (MS) and vertical and horizontal limbs of the diagonal band of Broca (DBB) and provide cholinergic innervation of the hippocampus and olfactory bulb. The fourth group (Ch4) of basal forebrain cholinergic neurons includes a loosely clustered arrangement of cholinergic neurons located in the nucleus basalis magnocellularis (nBM) and rostrally contiguous ventral pallidum/substantia innominata (Mesulam et al., 1983a,b) . These neurons project diffusely to all layers and areas of the neocortical mantle (Bigl et al., 1982; Struble et al., 1986) , in which the primary physiological effect of ACh is to modulate the response of pyramidal cells to other, particularly glutamatergic, cortical input (McCormick, 1993; Metherate and Ashe, 1993) . This innervation of the neocortex by basal forebrain cholinergic neurons is an important mediator of cortical activation in support of cognitive function. Correspondingly, electrical stimulation of the basal forebrain increases cortical ACh release and desynchronizes the cortical electroencephalogram (Kurosawa et al., 1989; Metherate et al., 1992; Rasmusson et al., 1992) . It has long been appreciated that the basal forebrain plays an important role in cognitive, and particularly attentional, function. For example, a series of important primate studies from the 1970s showed that (putatively cholinergic) basal forebrain neurons respond to food-related visual stimuli only when the animal was hungry Mora et al., 1976; Rolls et al., 1977 Rolls et al., , 1979 . These observations provided a clear demonstration that the interoceptive state of an animal modulates the ability of exteroceptive cues to drive forebrain attentional systems. However, interest in the cognitive functions of the basal forebrain cholinergic system (BFCS) accelerated greatly in the 1980s, spurred by the discovery that cholinergic cell loss is the primary neurotransmitter pathological hallmark of Alzheimer's disease (Whitehouse et al., 1982; McGeer et al., 1984) . Since that time, there has been much interest in the anatomical and molecular substrates that mediate cholinergic regulation of attention, learning, and memory in a variety of paradigms.
As the rostralmost component of the cortical mantle, the PFC derives its major cholinergic innervation from the Ch4 group of basal forebrain neurons. Some reports in rodents have suggested that a smaller portion of cholinergic innervation of the medial PFC additionally arises from the DBB and MS as well as from the pedunculopontine and laterodorsal tegmental areas of the brainstem (Lamour et al., 1984; Eckenstein et al., 1988) . Studies using immunotoxic lesions of cholinergic neurons in these areas similarly have suggested that cholinergic projections into the prelimbic and infralimbic cortex might be segregated throughout this continuum. These studies using immunotoxic lesions demonstrated significant loss of acetylcholinesterase staining in both hippocampus and PFC following injections into the basal forebrain or MS/ vertical DBB. In contrast, targeting the nBM/horizontal DBB affected predominantly cholinergic projections to the prelimbic cortex but spared hippocampal projections (Knox and Keller, 2015) .
In addition to the neocortex, the BFCS is also a primary source of cholinergic innervation of subcortical limbic structures, such as the hippocampus and the amygdala. In fact, cholinergic projections from the Ch4 subgroup form the densest source of neuromodulatory inputs to the amygdala, especially the BLA complex (Muller et al., 2011) . Although the functions of these cholinergic inputs are understudied, given the role of the BFCS in attention, one might predict that amygdalar ACh enhances the attentional processing of emotional states and the association of these states with neutral stimuli in the environment. Cholinergic inputs from the BFCS target both calcium/calmodulin kinase-positive (putatively glutamatergic) pyramidal neurons and parvalbumin-positive interneurons in the BLA, although the preponderance of cholinergic innervation is to glutamatergic projection neurons of the BLA (Muller et al., 2011) .
Anatomical studies have suggested that M1 and M2 mAChRs are selectively expressed in different components of the microcircuits in the amygdala, hippocampus, and PFC that receive cholinergic inputs from the BFCS. For the BLA, studies by McDonald and colleagues have shown that pyramidal cells express relatively high levels of M1 and M2 mAChR, although M1 receptors are localized in the perikarya, whereas both M1 and M2 receptors are found in dendritic shafts and spines of these cells (McDonald and Mascagni, 2010; Muller et al., 2013 Muller et al., , 2016 . For the PFC and the hippocampus, studies have similarly suggested that M1 (and M3) receptors are localized predominantly postsynaptically on glutamatergic pyramidal neurons (Rouse et al., 1998 (Rouse et al., , 1999 Volpicelli and Levey, 2004) . In the BLA, nonpyramidal inhibitory interneurons also express M1 and M2 mAChRs, although additional studies are required to determine whether mAChR expression differs among interneuronal cell types, as is seen in the hippocampus (Hajos et al., 1998) . In addition, cholinergic inputs from the BFCS into the BLA express only M2 receptors, suggesting a role in autoreceptor control of ACh release in this region, whereas GABAergic projections from the BFCS express both M1 and M2 mAChR subtypes (Muller et al., 2013 (Muller et al., , 2016 . This has similarly been demonstrated in hippocampus and PFC, in which cholinergic inputs from the BFCS and the MS have presynaptic M2 receptors (Rouse et al., 1999; Volpicelli and Levey, 2004) . The functional role of mAChRs on different cell types in the amygdala was similarly suggested by using optogenetic stimulation of cholinergic fibers in the BLA, which influenced both interneurons and pyramidal cells. Although the physiological effects differed according to cell type and stimulation parameters, the net effect of optogenetic activation was enhancement of the "signalto-noise ratio," similar to cholinergic modulation of neocortical pyramidal cells (Unal et al., 2015) . Muscarinic activation also increases excitability of infralimbic neurons by decreasing both M-type potassium conductance and potassium channel afterhyperpolarizations (AHPs; Santini and Porter, 2010; Santini et al., 2012) . However, muscarinic activation also decreases synaptic efficacy of hippocampal inputs into prelimbic cortex via M2 receptor activation (Wang and Yuan, 2009) . A subset of BLAprojecting cholinergic neurons from the basal forebrain may also be glutamatergic, as evidenced by immunohistochemical colocalization of choline acetyltransferase (ChAT) and the vesicular glutamate transporter-3 (Nickerson Poulin et al., 2006) .
Although cholinergic innervation of the cortical mantle is diffuse, reciprocal excitatory inputs from cortex back to the basal forebrain derive disproportionately from limbic-and paralimbic-associated areas, including prefrontal and agranular insular regions (Carnes et al., 1990; Zaborszky et al., 1997; Mesulam, 2013) . Additional major sources of inputs to the basal forebrain derive from the nucleus accumbens (Mogenson et al., 1983; Zaborszky and Cullinan, 1992) and parts of the amygdala (Grove, 1988) , although inputs from the central nucleus may be restricted to a caudal part of the basal forebrain cholinergic system (Gastard et al., 2002) . The Ch4 neurons also receive input from brainstem monoamines, including constituents of the ascending reticular activating system and its rostral extension in the ventral tegmental area (Jones and Cuello, 1989; Zaborszky, 1989; Smiley et al., 1999) and the hypothalamus (Zaborszky and Cullinan, 1989) . Thus, the BFCS is situated at the intersection of cortical, subcortical, diencephalic, and brainstem systems that form limbic and paralimbic circuits and is, therefore, ideally located to modulate cognitive correlates of emotional behaviors, including Pavlovian conditioning and extinction.
CHOLINERGIC REGULATION OF CONDITIONED FEAR AND EXTINCTION
Prefrontal cortical inputs to the amygdala play a critical role in the adaptive behavioral responses to threatening stimuli, particularly in extinction of the learned responses to such threats (Milad and Quirk, 2012; Baldi and Bucherelli, 2015) . As described above, the BLA receives very dense cholinergic innervation from the basal forebrain, suggesting that cholinergic neurotransmission also plays a central role in regulating amygdalar function. Furthermore, the cholinergic innervation of the PFC and the amygdala derives from a subregion of the basal forebrain separate from the cell groups that innervate the hippocampus. This anatomical segregation may, in part, underlie pharmacological findings (reviewed below) indicating distinct cholinergic regulation of contextually conditioned fear vs. cue-conditioned responses as well as differential regulation during extinction learning (see Fig. 1 ).
Pharmacological studies support a role for mAChRs in the amygdala, hippocampus, and PFC in regulating the formation and extinction of fear memories. Pharmacological interventions with muscarinic agonists or antagonists support the general premise that cholinergic activation of mAChRs contributes to memory processes during the acquisition and/or consolidation of fear learning and fear extinction. The role of nicotinic receptors (nAChRs) in fear learning and extinction is less clear, with modulatory effects generally reported for nAChR agonists (e.g., nicotine) but not antagonists.
CHOLINERGIC REGULATION OF CONTEXTUAL FEAR RESPONSES
Although there is some inconsistency in the literature, mAChR activation in the hippocampus appears particularly critical in the acquisition of contextual fear learning (see Tables I, II) . Several studies using various conditioning protocols have indicated that the systemic administration of the mAChR antagonist scopolamine before training can reduce the acquisition of conditioned fear as well as subsequent freezing responses when animals are re-exposed to the context (1 day or 1 week later; Anagnostaras et al., 1995 Anagnostaras et al., , 1999 Rudy, 1996; Lindner et al., 2006; see Table I ). Furthermore, administration of the M1-selective mAChR antagonist dicyclomine before training or testing similarly blocked contextual fear responses, and subeffective doses of dicyclomine also attenuated contextual fear responses when combined with subeffective doses of the NMDA antagonist MK801 (Fornari et al., 2000; Soares et al., 2006; Figueredo et al., 2008) . Similar decreases in contextual freezing were seen after scopolamine administration within 3 hr after the conditioning paradigm, although one of these studies used juvenile rats (Rudy, 1996; Bucherelli et al., 2006) . However, as displayed in Table I , other studies failed to see effects of scopolamine given after the training session on contextual fear responses even with high doses or in juvenile rats (Anagnostaras et al., 1995 (Anagnostaras et al., , 1999 Young et al., 1995) . Posttraining administration of dicyclomine also failed to alter contextual fear responses (Soares et al., 2006) . These differences in the effects of posttraining scopolamine have been attributed primarily to the variable conditioning protocols, including the number and timing of the tone-shock pairings during acquisition as well as the injection time points, dose, and potentially age or sex of the subjects (see Tinsley, 2004) . The inhibitory effects of systemic scopolamine on contextual fear conditioning were not seen with methylscopolamine, suggesting that the effects were due to central rather than peripheral block of mAChR because methylscopolamine does not cross the blood-brain barrier (Anagnostaras et al., 1999) .
Activation of nAChRs also modulates fearconditioned responses (see Gould and Leach, 2014; Kutlu and Gould, 2015;  Table I ). Systemic administration of nicotine before both the training and the testing session enhanced contextual fear responses in a dose-dependent manner (Gould and Wehner, 1999; Wehner et al., 2004; . These effects were seen both 1 and 7 days after training but only when nicotine was administered before both the training and testing sessions (Gould and Wehner, 1999; Gould and Higgins, 2003) . Unlike what is seen with muscarinic antagonists, systemic Fig. 1 . A: Diagram illustrates the primary cholinergic inputs from the MS into the hippocampus and the BFCS into the PFC and amygdala. C: During Pavlovian fear conditioning, a CS, such as a tone, is paired with a US, such as a foot shock. Animals show conditioned freezing after return to the conditioning context (context A) or cue-conditioned freezing after presentation of the tone in a novel environment (context B). Repeated exposure to the tone elicits extinction learning, which involves corticoamygdalar circuits and results in reduced freezing behaviors. B: Pharmacological interventions with mAChR or nAChR agonists and antagonists suggest that muscarinic activation enhances contextual fear conditioning primarily through interactions in the hippocampus, whereas muscarinic activation through the BFCS inputs into PFC and amygdala enhance fear extinction processes. Nicotinic agonists generally enhance contextual fear conditioning and extinction, but the effects of nAChR antagonists appear to be dependent on receptor subtype in specific subregions of these brain areas. See Tables I-III for summaries of these effects and references. pretraining administration of the nAChR antagonists mecamylamine (MEC) or dihydro-b-erythroidine (DHbE) did not alter contextual fear-conditioned responses on their own but could block the actions of nicotine (Gould and Wehner, 1999; Gould and Higgins, 2003; Feiro and Gould, 2005; . The lack of effects with nicotinic antagonists might suggest that effects of endogenous release of ACh associated with fear conditioning are mediated mostly via mAChRs or that nicotinic effects depend on coincident activation of both mAChRs and nAChRs. The requirement for coactivation of both receptors is supported by a study in which the combined administration of subthreshold doses of MEC and scopolamine were able to decrease contextual and cued fear responses in young but not old mice (Feiro and Gould, 2005) . The lack of nAChR antagonist effects might also be related to cholinergic effects at different nAChR subtypes that influence fear learning at different time points during acquisition or consolidation, as suggested by microinjection studies (see Vago and Kesner, 2007 , and below). Nicotine's effects appear to be mediated via b2-containing receptors because the ability of nicotine to enhance fear responses was blocked by the a4b2 antagonist DHbE, and contextual freezing was increased by administration of the partial a4b2 agonist ABT-089 given both pretraining and pretesting Yildirim et al., 2015) . In contrast, varenicline, which is a partial a4b2 agonist but a full a7 agonist, failed to affect contextual freezing when given before testing, before training, or both (Raybuck et al., 2008) . Furthermore, mice lacking the b2 subunit of the nAChR showed reduced contextual fear responses as well as a lack of nicotine's effects on contextual fear responses (Wehner et al., 2004; Davis and Gould, 2007) . Mice lacking the a7, b3, or b4 nAChR subunits did not show any deficits in contextual fear, although administration of the a7 selective antagonist methyllycaconitine (MLA) into the ventral hippocampus blocked the influences of systemic nicotine on contextual fear responses (Wehner et al., 2004; Kenney et al., 2012) , and systemic administration of MLA (without nicotine) increased contextual fear responses . An agonist at homomeric a7 nAChRs (ABT-107), however, failed to increase contextual fear (Yildirim et al., 2015) . Decreased contextual fear responses were seen in mice during spontaneous or precipitated nicotine withdrawal, and this reduction during nicotine withdrawal was not seen in mice lacking the b2 nAChR subunit . Nicotine withdrawal effects are also reversed with the a4b2-selective partial agonists ABT-089 and varenicline as well as acetylcholinesterase inhibitors such as donepezil and galantamine (Raybuck et al., 2008; Wilkinson and Gould, 2011; Poole et al., 2014; Yildirim et al., 2015) . Much higher doses of donepezil or galantamine were required to enhance conditioned fear responses in nondependent animals, and these effects were associated with enhanced acquisition of conditioned responses and/or unconditioned freezing (Wilkinson and Gould, 2011; Poole et al., 2014) . Thus, although nicotine can modify contextual fear responses, only a few studies have shown effects of nAChR antagonists or acetylcholinesterase inhibitors (see Table I ). The more consistent effects of scopolamine on contextual fear conditioning suggest that cholinergic influences on contextual fear conditioning are mediated primarily through mAChR activation or that different nAChR subtypes have opposing effects on conditioned fear responses.
Microinjection studies further implicate cholinergic processes in the hippocampus and amygdala in regulating the acquisition and consolidation of contextual fear learning (see Table II ). Microinjection of scopolamine into the hippocampus blocked acquisition and/or expression of contextual freezing responses when administered before or immediately after the conditioning paradigm (Gale et al., 2001; Wallenstein and Vago, 2001; Rogers and Kesner, 2004; Chang and Liang, 2012) . Similarly, immediate posttraining microinjection of scopolamine into the BLA attenuated contextual fear responses 72 hr later (Passani et al., 2001) . Unfortunately, the results of this study were slightly confounded by performing the posttraining microinjection under ketamine anesthesia. In addition, posttraining injections of the muscarinic agonist oxotremorine into the BLA enhanced contextual responses (Vazdarjanova and McGaugh, 1999; Cangioli et al., 2002) . In contrast, pretraining scopolamine injections into the lateral as opposed to the basolateral amygdala did not attenuate contextual fear responses (Baysinger et al., 2012) . In studies that observed posttraining effects of scopolamine, administration of the mAChR antagonist more than 6 hr after conditioning sessions failed to affect contextual fear responses (Rudy, 1996; Chang and Liang, 2012) .
Microinjection studies also suggest that the modulatory influences of nAChR activation are dependent on regionally-specific interactions with different receptor subtypes (see Table II ), which may explain the lack of robust or consistent effects following the systemic administration of nonselective nAChR antagonists. Pretraining microinjections of nicotine into the dorsal hippocampus enhanced contextual fear conditioning, whereas nicotine injections into the ventral hippocampus decreased this response, and injections into the PFC had no effect (Raybuck and Kenney et al., 2012) . Injections of the nonselective antagonist MEC into the dorsal hippocampus either pre-or immediately posttraining attenuated contextual fear responses but not when MEC was administered 6 hr after training. In contrast, pretraining administration of the a7 selective antagonist MLA in the dorsal or ventral hippocampus had no effect on contextual fear responses (Vago and Kesner, 2007; Kenney et al., 2012) , but posttraining injections of MLA up to 6 hr after training decreased contextual freezing (Vago and Kesner, 2007) . Furthermore, blocking a7 nAChRs in ventral hippocampus along with systemic administration of nicotine before training enhanced contextual freezing, suggesting that blocking these receptors in ventral hippocampus permitted actions of nicotine in the dorsal hippocampus to enhance contextual fear responses (Kenney et al., 2012) .
In the dorsal hippocampus, injections of nicotine or nAChR antagonists administered only before testing did not alter contextual fear responses. In contrast, injections of DHbE in the ventral hippocampus and injections of MLA or DHbE into the PFC were able to decrease contextual fear responses when administered prior to the retention test (Raybuck and Gould, 2010; Kenney et al., 2012) . Such opposing effects of nAChRs in different brain areas may help to explain the lack of effects on contextual fear conditioning with systemic administration of nAChR blockers (especially nonselective blockers).
CHOLINERGIC REGULATION OF CUE-CONDITIONED FEAR AND EXTINCTION
The role of cholinergic processes in mediating the formation or expression of cued fear responses in delay conditioning protocols is less clear (see Tables I, II) . Although a few studies have also demonstrated that systemic administration of scopolamine before (Young et al., 1995; Rudy, 1996; Anagnostaras et al., 1999; Feiro and Gould, 2005) or just after (Rudy, 1996) conditioning attenuated freezing responses to an auditory CS, this appears to require higher doses of scopolamine, and the posttraining effects of scopolamine are not uniformly observed (see Anagnostaras et al., 1999; Tinsley, 2004) . Furthermore, administration of the M1 mAChR antagonist dicyclomine, even at doses fourfold those required to attenuate contextual fear responses, failed to modify freezing to the tone (Fornari et al., 2000) . In general, systemic administration of nicotine or subtype selective agonists at doses that enhance contextual fear conditioning failed to modify cue-conditioned responses (Gould and Wehner, 1999; Gould et al., 2004; Wehner et al., 2004; Yildirim et al., 2015) . Although increased responses to the CS were seen in some studies with high doses of nicotine, these appeared to be nonspecific effects potentially related to nicotine-induced increases in startle responses (Gould and Higgins, 2003) . Pretraining administration of MEC similarly failed to alter conditioned responses to the CS (Feiro and Gould, 2005) . Administration of a combination of mAChR and nAChR antagonists (MEC and atropine) into the BLA before training, however, decreased cueinduced freezing during recall and enhanced extinction learning. Administration of atropine alone had no effect on these responses, implicating nicotinic effects in this study (Jiang et al., 2016) . Administration of scopolamine, nicotine, or nicotinic antagonists directly into the hippocampus also failed to attenuate cue-conditioned responses, supporting the role of the hippocampus primarily in contextual information processing (Gale et al., 2001; Wallenstein and Vago, 2001; Rogers and Kesner, 2004; Vago and Kesner, 2007; Kenney et al., 2012) . Although the neural underpinnings of trace conditioning differ from delayed cue or contextual conditioning, a few studies have implicated cholinergic (both muscarinic and nicotinic) mechanisms in this type of protocol as well (Raybuck and Gould, 2010; Baysinger et al., 2012) .
In contrast, activation of mAChR, particularly in the PFC and the amygdala, appears to play an important role in the encoding of extinction learning, including extinction of responses to a conditioned cue (see Table  III ). In animals conditioned to an auditory CS, administration of the mAChR antagonist scopolamine immediately before or after extinction training attenuated extinction recall; these effects were seen with both systemic and local administration into the infralimbic PFC (Santini et al., 2012) . Unfortunately, the testing of extinction in the same context as training in this study cannot completely rule out cholinergic influences on contextual fear processes during extinction recall (Santini et al., 2012) . In an intriguing study by Fanselow and colleagues, low systemic doses of scopolamine (0.1 mg/kg) prior to extinction training appeared to shift the nature of the extinction memory. Although animals treated with low doses of scopolamine showed a slower rate of long-term extinction memory formation (e.g., the requirement for more extinction training sessions), there was an attenuation of fear renewal even if subjects were tested in a novel context. These effects were not observed with posttraining injections of scopolamine (Zelikowsky et al., 2013) , suggesting that pretraining administration of mAChR antagonists may be related to modulating contextual information during these paradigms (see discussion below). Furthermore, administration of mAChR agonists can also improve extinction learning or recall. The muscarinic agonist cevimeline enhanced extinction learning when the drug was given either before or immediately after daily extinction training sessions (Santini et al., 2012) , although these studies were performed with animals undergoing extinction in the training context, so effects on contextual information cannot be dismissed. Administration of the mAChR agonist oxotremorine unilaterally into the BLA, however, also improved extinction of contextual fear (Boccia et al., 2009) . Although data with classical conditioning are limited, posttraining systemic and intracerebral injections of oxotremorine into the BLA similarly accelerated the extinction of amphetamine-conditioned place preference (Schroeder and Packard, 2004) , perhaps suggesting a generalized effect of muscarinic activation in extinction processes.
The effects of nicotine on extinction, however, appear to be dependent on the extinction protocol, when nicotine is administered, and whether extinction is tested in the same or different contexts (see Table III ); reports assessing effects of nAChR antagonists in extinction trials are lacking. Nicotine given before the extinction trials impaired extinction to the context and appeared to delay extinction over multiple trials. This study suggested that nicotine might have enhanced the recall of the original fear memory during these trials (Kutlu and Gould, 2014) . Chronic nicotine administration given 2 weeks prior to the conditioning protocol also impaired between-trial extinction to the CS but not extinction to the context (Tian et al., 2008) . Nicotine administered before extinction training trials enhanced between-trial extinction of responses to the cue over 5 days and reduced renewal of the original fear memory (Elias et al., 2010) . Administration of the nicotine metabolite cotinine, considered a positive modulator of a7 containing nAChRs, also enhanced fear extinction in mice (Zeitlin et al., 2012; Barreto et al., 2015) . Overall, these studies suggest that mAChR activation in the PFC and the BLA enhance memory consolidation during extinction training (see Fig. 1 ). In contrast, it appears that the effects of nAChR activation activity might either delay or enhance extinction, depending on the timing of agonist administration or perhaps the subtype selectivity of the agonist.
NEUROCHEMICAL STUDIES OF CHOLINERGIC REGULATION OF FEAR
LEARNING AND EXTINCTION As summarized in Figure 1 , pharmacological evidence supports the notion that cholinergic, particularly muscarinic, activation enhances the consolidation of memory formation (Power et al., 2003a) . Others have also suggested that the release of ACh is important in activating neural systems during learning and may mediate individual differences seen in several learning paradigms, including aversive conditioning (Gold, 2003) . Posttraining activation of mAChR or other treatments that increase ACh release in the BLA, such as glucose or H3 histamine agonists, enhance contextual fear responses (Passani et al., 2001; Cangioli et al., 2002; Santini et al., 2012) as well as accelerating or improving extinction of conditioned responses (Schroeder and Packard, 2004; Boccia et al., 2009; Santini et al., 2012) . Similarly, muscarinic antagonists can delay or attenuate extinction learning (Maruki et al., 2003; Santini et al., 2012; Zelikowsky et al., 2013) , suggesting that muscarinic cholinergic activation is critical in this process. Activation of nAChRs with nicotine or cotinine can also enhance extinction learning (Elias et al., 2010; Zeitlin et al., 2012; Barreto et al., 2015) , so it is possible that ACh release could enhance both muscarinic and nicotinic neurotransmission in regions such as the PFC, hippocampus, and amygdala that are critical for extinction processes.
In support of this notion, several microdialysis studies have demonstrated an association between ACh release in the hippocampus, PFC, and amygdala and associative learning responses, although only a few studies have specifically examined ACh efflux during Pavlovian fear conditioning or extinction. Increases in ACh efflux are seen during fear conditioning procedures, and, in hippocampus, unpaired shocks and tones led to higher efflux than tones paired with shocks (Nail-Boucherie et al., 2000; Calandreau et al., 2006) . Exposure to a conditioned cue or context or objects in a novel object task also increases ACh in the hippocampus and/or PFC (Acquas et al., 1996; Nail-Boucherie et al., 2000; Stanley et al., 2012) , and ACh released in the PFC is increased during extinction of an operant task (Izaki et al., 2001 ). In addition, activation of histaminergic H3 receptors increases ACh release in the BLA and improves the expression of fear memories (Cangioli et al., 2002) . These studies are consistent with the notion that cholinergic systems originating in the basal forebrain are activated and enhance ACh efflux, presumably resulting in increased endogenous tone on cholinergic receptors; in cortical, hippocampal, and amygdalar projection areas during exposure to conditioned cues or contexts; and also during extinction training. Recent studies by Jiang and coworkers (2016) with pharmacological and optogenetic techniques to activate or inhibit cholinergic inputs into the BLA during training support this notion. Coadministration of nAChR and mAChR antagonists into the BLA reduced freezing to the CS and enhanced extinction (Jiang et al., 2016) . Optogenetic activation of the BFCS failed to change cueinduced freezing during the retention trial but attenuated extinction training, whereas optogenetic inhibition decreased freezing during training and cue presentation 24 hr later (Jiang et al., 2016) .
Studies diminishing ACh efflux with immunotoxic lesions of cholinergic neurons support the role of cholinergic inputs to hippocampus and/or cortical-amygdalar regions in modulating specific aspects of fear extinction processes, but not the acquisition or consolidation of contextual or cued fear learning. Although lesions of the basal forebrain cholinergic system with 192-IgG saporin failed to alter cue-conditioned responses, these lesions spared cholinergic projections to the amygdala (Conner et al., 2003) . In addition, immunotoxic lesions of the BFCS either preconditioning or postconditioning did not significantly diminish either acquisition or expression of contextual freezing, although pretesting lesions did significantly reduce ultrasonic vocalizations after return to the context (Frick et al., 2004) . Immunotoxic lesions of the MS that reduced cholinergic inputs to the hippocampus failed to shift acquisition of contextual fear responses or modify cFos activation of CA1 neurons associated with that response. In contrast, these MS lesions specifically attenuated extinction of contextual fear responses and the induction of ERK-positive neurons in the dorsal hippocampus associated with extinction processes (Tronson et al., 2009) . Similarly, lesions of either the basal forebrain or the MS/ventral DBB regions that reduced cholinergic inputs to the PFC and the hippocampus led to generalization of contextual fear memories that were resistant to extinction as well as an attenuated acquisition of cued fear extinction. These changes in extinction of contextual fear memories or acquisition of cued fear extinction were not seen with specific lesions of the nBM and horizontal limb of the DBB (Knox and Keller, 2015) . Lesions of these regions did not modulate acquisition of conditioned responses. Although these studies by Knox and Keller (2015) did not analyze decrements in cholinergic inputs to the amygdala, they contribute to the notion that corticohippocampal circuits play a role in acquisition, expression, and generalization of contextual fear memories and that contextual information is important during extinction learning (Rozeske et al., 2015) .
Several studies have examined changes in various markers of cholinergic function associated with fear learning or extinction paradigms and have suggested that individual differences in these indices of cholinergic function may be correlated with behavioral responses during learning tasks, including conditioned fear responses. The expression of ChAT mRNA is enhanced by cue conditioning, although these changes were seen in the caudal nBM regions that specifically projected to the auditory cortex (Oh et al., 1992) . Furthermore, although no studies have examined receptor changes after classical conditioning procedures, immunoreactive mAChR staining was increased in the central amygdala and decreased in the corticomedial amygdala after training in an active avoidance paradigm, and these changes persisted for at least 25 days . Such changes in mAChR staining were suggestive of functional activation of mAChRs in the amygdala in response to a conditioning protocol. Furthermore, correlative relationships have been observed between various indices of cholinergic function and behavioral endpoints in several aversive learning tasks McIntyre et al., 2002; Gold, 2003) . In an operant task, ACh release in the PFC was negatively correlated with lever presses during extinction, suggesting that heightened ACh release was associated with enhanced extinction learning (Izaki et al., 2001 ). This finding is also in line with other studies demonstrating that cognitive and motoric correlates of ACh release in the cortex can be dissociated (Himmelheber et al., 2000) . In addition, mAChR immunoreactivity in the central amygdala of na€ ıve rats showed large individual variations, and mAChR immunoreactivity was positively correlated with immobility in a conditioned task van der Zee and Luiten, 1999) . These mAChR-positive cells are GABAergic neurons that also express nAChRs and are densely packed in the lateral portions of the central nucleus . Although few human studies have directly investigated cholinergic systems associated with fear extinction, a recent neuroimaging study has suggested that the BFCS enhances amygdala connectivity with both the PFC and the hippocampus during the processing of biologically salient stimuli in humans, and the magnitude of this effect was predicted by functional variation within the choline transporter gene (Gorka et al., 2015) .
PHYSIOLOGY OF CHOLINERGIC REGULATION OF FEAR LEARNING AND
EXTINCTION Physiological studies have begun to elucidate regionspecific responses that will be required to integrate pharmacological and neurochemical findings into understanding how cholinergic modulation of neuronal circuits regulates fear learning and extinction. The demonstration that fear conditioning and fear extinction processes involve segregated cell types and signaling cascades within the neuronal networks makes this a challenging undertaking that will clearly require innovative approaches (Herry et al., 2008; Tronson et al., 2009) . In auditory fear learning, cholinergic projections activate layer 1 neurons in auditory cortex during contingent presentation of foot shock with tones, and this activation disinhibits pyramidal neurons via parvalbumin-positive inhibitory interneurons of layers 2/3 (Letzkus et al., 2011 (Letzkus et al., , 2015 . Cholinergic disinhibition of pyramidal neurons was blocked by a combination of MEC and MLA, implicating nAChRs in these effects. Microinjection of nAChR antagonists in auditory cortex also blocked freezing in response to conditioned auditory cues, although freezing in response to both the CS 1 and the CS -was reduced (Letzkus et al., 2011 (Letzkus et al., , 2015 . The authors speculate that cholinergic regulation of pyramidal neuron outputs via disinhibition is seen in other areas with microcircuits similar to those in the cortex involving parvalbumin interneurons, such as BLA (Letzkus et al., 2015) .
In the hippocampus, exposure to a novel environment causes remapping of place cells and a shift in theta (4-12 Hz) oscillations toward encoding (Douchamps et al., 2013) . Fear conditioning also induces a synchrony of theta oscillations among hippocampus (CA1), lateral amygdala, and PFC; this synchrony is disrupted by repeated exposure to the conditioned context and partially rebounds during extinction recall (Lesting et al., 2011) . Extinction of contextually conditioned freezing in response to a predator odor induces a remapping by some hippocampal place cells, whereas some place cells remain stable, suggesting that these shifts may help in the modification of preexisting contextual memories as well as the formation of new ones during extinction (Wang et al., 2015) . Furthermore, the remapping of hippocampal place cells in a novel environment as well as the shifts in theta oscillations toward encoding (pyramidal-layer theta peak) are both disrupted with the muscarinic antagonist scopolamine, suggesting a key role for cholinergic inputs in modulating these responses and providing contextual information during fear learning and extinction (Douchamps et al., 2013) .
In the PFC, activation of mAChRs increases excitability of infralimbic neurons via decreased M-type potassium currents and potassium channel AHPs, and these changes are linked to modulating extinction recall (Santini and Porter, 2010; Santini et al., 2012) . Activation of mAChRs in prelimbic cortex by carbachol causes both acute and long-term depression (LTD) of synaptic efficacy from hippocampal but not cortical inputs. The effects of carbachol required activation of the hippocampal inputs for induction of LTD and appeared to be mediated via M2 mAChRs (both presynaptic and postsynaptic) in this region (Wang and Yuan, 2009 ).
In the BLA, optogenetic stimulation of basal forebrain cholinergic inputs shows differential activitydependent effects on pyramidal neurons, suggesting that cholinergic regulation of this region enhances the signalto-noise ratio, activity, and plasticity (Unal et al., 2015; Jiang et al., 2016) . At low firing rates in pyramidal cells, optogenetic activation of the basal forebrain decreased activity of these neurons, whereas, during periods of higher baseline activity, basal forebrain activation induced an early nAChR activation of GABAergic interneurons, followed by direct M1 mAChR activation of an inward rectifying potassium channel (Unal et al., 2015) . These effects on pyramidal neurons were not observed with carbachol application in slices, suggesting that such divergent effects of cholinergic stimulation may be dependent on endogenous cholinergic release acting on the circuit as a whole as opposed to specific stimulation of a single mAChR or nAChR type. This is similar to findings in prelimbic cortex with carbachol (Wang and Yuan, 2009 ). In support of this notion, mice with M1 or M2 mAChR deficiencies or mice lacking nAChR subtypes generally failed to demonstrate alterations in cue conditioning (Anagnostaras et al., 2003; Bainbridge et al., 2008) , although one study showed a decrease in cue conditioning in M1 knockout mice (Miyakawa et al., 2001) . Furthermore, Young and Thomas (2014) demonstrated that muscarinic effects on consolidation of cued fear memories act in concert with signaling induced by b-adrenergic and dopaminergic receptors (Young and Thomas, 2014) , again suggesting that cholinergic regulation may be required to modulate circuit dynamics during fear extinction processes. In further support of this, studies from another group using in vivo and ex vivo optogenetic stimulation demonstrated that, after a brief (400 msec) pause, stimulation of cholinergic inputs induced a sustained increase in putative BLA pyramidal cell firing via enhanced glutamatergic neurotransmission and also decreased the threshold for long-term potentiation (Jiang et al., 2016) . These effects of cholinergic stimulation on BLA neurons were blocked by coadministration of MEC and atropine, although many of these effects seem to occur predominantly via nAChR activation (Jiang et al., 2016) . This is consistent with prior work of Jiang and Role (2008) showing that acute nicotine administration facilitated glutamatergic postsynaptic currents in the BLA and facilitated synaptic responses during activation of cortical inputs.
In summary, evidence suggests that cholinergic processes are involved in extinction learning and that activation of mAChRs and nAChRs in the corticohippocampal or corticoamygdalar circuits may regulate activity of these regions during acquisition of contextual or cued fear extinction, respectively (see Fig. 1 ). The indication that fear conditioning induces a coupling of theta oscillations among the CA1 hippocampus, infralimbic PFC, and lateral amygdala that is uncoupled during fear extinction paradigms and only partially rebounds during extinction recall supports the possibility that cholinergic mechanisms in these separate regions regulate synchrony in this network (Lesting et al., 2011 (Lesting et al., , 2013 . Validation of this concept requires additional studies using pharmacological manipulations or optogenetic stimulation of the cholinergic system during analysis of theta oscillations, but studies in the hippocampus suggest that cholinergic regulation of theta oscillations is likely (Douchamps et al., 2013) .
CONCLUSIONS
Both the acquisition of fear conditioning and the extinction of conditioned fear responses require plasticity of associations between sensory stimuli and behavioral processes. It has been well established that cholinergicreceptive brain regions such as the PFC, hippocampus, and amygdala play crucial roles in fear learning and extinction, although the specific contribution of cholinergic mechanisms to these phenomena remains poorly understood. A growing body of literature indicates a fundamental role for cholinergic regulation in the consolidation of learning responses, including fear learning, and especially in acquisition of fear extinction (see Fig. 1 ). The basal forebrain projects to the regions known to be involved in fear extinction learning and recall, and several emerging lines of evidence suggest that cholinergic modulation of the corticohippocampal-amygdalar circuit may regulate specific aspects of fear learning and extinction. Additional studies are required to determine the exact mechanisms and relative involvement of ACh release, activation of mAChR, and nAChR activation on distinct signaling pathways and different cell types in fear learning and extinction processes. Furthermore, it will be interesting to discover whether individual differences in pre-or postsynaptic indices of cholinergic neurotransmission mediate variations in animal models of fear extinction and, perhaps, have translational potential for disorders of fear and anxiety involving memory processes, such as posttraumatic stress disorder.
